glutathione kills triple negative cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy GPX4 in triple-negative breast cancer:
GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Tumor targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Nature Communications Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis World Journal of Surgical Oncology Springer Nature Link
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





